Optimal Selection test for Feline breeders is launched making it the first panel disease and trait test for felines on the market.
Wisdom Panel 4.0 testing with the addition of trait analysis and EIC screening is launched.
A Division of Mars Petcare completes the transition of Mars Veterinary into the Mars Petcare segment.
Wisdom Panel 2.5 and 3.0 are launched into the consumer channel featuring MDR1 testing.
Wisdom Panel 2.0 is launched into the consumer channel.
Banfield CTS headquarters becomes the permanent home of the Mars Veterinary Business unit.
Wisdom Panel Insights is launched into the consumer channel.
Wisdom Panel MX is launched into the U.S. veterinary channel.
A Division of Mars Symbioscience is formed and Mars Veterinary becomes part of the Symbioscience incubator segment based at Nottingham Laboratory.
The Breed Determination Patent is licensed from the Fred Hutchinson Cancer Research Center.
Genomics Technology Platform (Profile Technology) is created for researching canine DNA solutions at Waltham and Nottingham University Laboratories.